« Return to News | Clinical Intelligence

Top Stories for the Week of Jan. 15th 2007

Monday, January 15, 2007 05:33 AM

Top News

Clinical Financial Services Gets Additional Funding to Grow Sponsor Service Offerings

Pennsylvania-based Clinical Financial Services (CFS), a financial administration business focused on the clinical trial industry, has received a round of equity investments totaling $800,000 from Archbrook Capital Management, and private investors Anthony Kelly and George Hubley.

FDA Tells Sponsors to Review MDS Pharma Services Pharmacokinetic Results

The U.S. Food and Drug Administration (FDA) has notified more than 1,000 pharmaceutical and generic drug manufacturers to review the validity of any pharmacokinetic (PK) data conducted at two MDS Pharma Serviceslaboratories,tested from 2000 through 2004. The FDA's request only concerns branded or generic drugs already approved or drugs awaiting regulatory approval.

Other breaking news...

Company Profile: An interview with Laurent Hermoye, researcher and webmaster Volterys

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.